SUNPHARMA — Sun Pharmaceutical Industries Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹3.65tn
- IN₹3.55tn
- IN₹438.86bn
- 96
- 12
- 98
- 84
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 38,102 | 50,096 | 27,994 | 44,813 | 94,084 |
Depreciation | |||||
Non-Cash Items | 2,154 | -602 | -2,701 | -1,688 | 1,931 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -35,369 | -4,474 | 15,612 | 25,697 | -66,050 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 22,420 | 65,548 | 61,704 | 90,260 | 55,260 |
Capital Expenditures | -32,128 | -15,420 | -11,701 | -14,950 | -20,856 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 25,316 | -10,468 | 17,064 | -42,297 | -58,581 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -6,813 | -25,888 | 5,362 | -57,247 | -79,437 |
Financing Cash Flow Items | -20,135 | -12,130 | 686 | -2,692 | -1,001 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -27,305 | -57,151 | -59,805 | -51,935 | 23,761 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -8,442 | -13,857 | 5,964 | -17,648 | 1,155 |